Vanguard Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.5B | Buy |
14,392,082
+140,450
| +1% | +$25.6M | 0.04% | 429 |
|
|
2025
Q3 | $2.72B | Buy |
14,251,632
+18,056
| +0.1% | +$3.2M | 0.04% | 407 |
|
|
2025
Q2 | $2.56B | Buy |
14,233,576
+296,860
| +2% | +$51.6M | 0.04% | 404 |
|
|
2025
Q1 | $2.36B | Sell |
13,936,716
-23,742
| -0.2% | -$3.9M | 0.04% | 407 |
|
|
2024
Q4 | $2.11B | Sell |
13,960,458
-10,093
| -0.1% | -$1.57M | 0.04% | 445 |
|
|
2024
Q3 | $2.17B | Buy |
13,970,551
+18,751
| +0.1% | +$2.8M | 0.04% | 434 |
|
|
2024
Q2 | $1.91B | Buy |
13,951,800
+29,845
| +0.2% | +$4.09M | 0.04% | 448 |
|
|
2024
Q1 | $1.85B | Buy |
13,921,955
+345,754
| +3% | +$44.9M | 0.04% | 468 |
|
|
2023
Q4 | $1.87B | Sell |
13,576,201
-47,930
| -0.4% | -$6.3M | 0.04% | 445 |
|
|
2023
Q3 | $1.66B | Sell |
13,624,131
-119,835
| -0.9% | -$16M | 0.04% | 443 |
|
|
2023
Q2 | $1.93B | Buy |
13,743,966
+47,880
| +0.3% | +$6.6M | 0.05% | 416 |
|
|
2023
Q1 | $1.94B | Sell |
13,696,086
-277,253
| -2% | -$39.7M | 0.05% | 405 |
|
|
2022
Q4 | $2.19B | Sell |
13,973,339
-183,563
| -1% | -$26.4M | 0.06% | 362 |
|
|
2022
Q3 | $1.74B | Buy |
14,156,902
+90,362
| +0.6% | +$11.9M | 0.05% | 395 |
|
|
2022
Q2 | $1.87B | Buy |
14,066,540
+52,510
| +0.4% | +$7.16M | 0.05% | 385 |
|
|
2022
Q1 | $1.92B | Buy |
14,014,030
+636,301
| +5% | +$88.7M | 0.05% | 431 |
|
|
2021
Q4 | $2.31B | Buy |
13,377,729
+92,228
| +0.7% | +$14M | 0.05% | 390 |
|
|
2021
Q3 | $1.93B | Sell |
13,285,501
-796,219
| -6% | -$117M | 0.05% | 431 |
|
|
2021
Q2 | $1.86B | Sell |
14,081,720
-221,696
| -2% | -$29M | 0.05% | 448 |
|
|
2021
Q1 | $1.84B | Sell |
14,303,416
-34,269
| -0.2% | -$4.22M | 0.05% | 415 |
|
|
2020
Q4 | $1.71B | Sell |
14,337,685
-291,871
| -2% | -$35.6M | 0.05% | 410 |
|
|
2020
Q3 | $1.67B | Sell |
14,629,556
-632,120
| -4% | -$74.7M | 0.06% | 364 |
|
|
2020
Q2 | $1.74B | Sell |
15,261,676
-496,159
| -3% | -$52.6M | 0.06% | 333 |
|
|
2020
Q1 | $1.27B | Buy |
15,757,835
+362,905
| +2% | +$37.6M | 0.05% | 369 |
|
|
2019
Q4 | $1.64B | Buy |
15,394,930
+166,770
| +1% | +$17.4M | 0.06% | 384 |
|
|
2019
Q3 | $1.63B | Buy |
15,228,160
+264,888
| +2% | +$27.2M | 0.06% | 357 |
|
|
2019
Q2 | $1.52B | Buy |
14,963,272
+89,648
| +0.6% | +$8.61M | 0.06% | 369 |
|
|
2019
Q1 | $1.34B | Sell |
14,873,624
-10,403
| -0.1% | -$901K | 0.05% | 406 |
|
|
2018
Q4 | $1.24B | Buy |
14,884,027
+383,737
| +3% | +$36M | 0.06% | 379 |
|
|
2018
Q3 | $1.56B | Buy |
14,500,290
+201,951
| +1% | +$22.1M | 0.06% | 356 |
|
|
2018
Q2 | $1.57B | Buy |
14,298,339
+48,588
| +0.3% | +$5.06M | 0.07% | 336 |
|
|
2018
Q1 | $1.43B | Buy |
14,249,751
+180,327
| +1% | +$18.5M | 0.06% | 367 |
|
|
2017
Q4 | $1.39B | Sell |
14,069,424
-287,501
| -2% | -$27.3M | 0.06% | 378 |
|
|
2017
Q3 | $1.34B | Buy |
14,356,925
+327,603
| +2% | +$34.8M | 0.06% | 358 |
|
|
2017
Q2 | $1.56B | Buy |
14,029,322
+525,200
| +4% | +$55.5M | 0.08% | 287 |
|
|
2017
Q1 | $1.33B | Sell |
13,504,122
-50,485
| -0.4% | -$4.81M | 0.07% | 326 |
|
|
2016
Q4 | $1.25B | Buy |
13,554,607
+314,660
| +2% | +$27.1M | 0.07% | 323 |
|
|
2016
Q3 | $1.12B | Buy |
13,239,947
+327,141
| +3% | +$27.5M | 0.07% | 344 |
|
|
2016
Q2 | $1.05B | Buy |
12,912,806
+233,179
| +2% | +$17.8M | 0.07% | 338 |
|
|
2016
Q1 | $906M | Buy |
12,679,627
+370,896
| +3% | +$24.9M | 0.06% | 382 |
|
|
2015
Q4 | $876M | Buy |
12,308,731
+341,182
| +3% | +$22.9M | 0.06% | 366 |
|
|
2015
Q3 | $736M | Sell |
11,967,549
-287,939
| -2% | -$20.1M | 0.05% | 414 |
|
|
2015
Q2 | $889M | Buy |
12,255,488
+223,508
| +2% | +$16.5M | 0.06% | 367 |
|
|
2015
Q1 | $925M | Buy |
12,031,980
+887,970
| +8% | +$63.6M | 0.06% | 353 |
|
|
2014
Q4 | $747M | Buy |
11,144,010
+359,746
| +3% | +$22.7M | 0.05% | 403 |
|
|
2014
Q3 | $654M | Buy |
10,784,264
+393,978
| +4% | +$24.3M | 0.05% | 421 |
|
|
2014
Q2 | $610M | Buy |
10,390,286
+240,992
| +2% | +$14.1M | 0.05% | 440 |
|
|
2014
Q1 | $588M | Buy |
10,149,294
+460,912
| +5% | +$24.7M | 0.05% | 428 |
|
|
2013
Q4 | $519M | Sell |
9,688,382
-197,892
| -2% | -$11.7M | 0.05% | 458 |
|
|
2013
Q3 | $611M | Sell |
9,886,274
-92,073
| -0.9% | -$5.51M | 0.06% | 367 |
|
|
2013
Q2 | $605M | Buy |
+9,978,347
| New | +$594M | 0.06% | 342 |
|
Other funds holding DGX
Vanguard Group's DGX Position: Q4 2025 in Review
Vanguard Group increased its Quest Diagnostics (DGX) stake by 0.99% in Q4 2025, buying an estimated $25.6M and bringing the position to 14,392,082 shares worth $2.5B. The position accounts for 0.04% of the portfolio, ranked #429.
Vanguard Group first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.72B in Q3 2025. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- Vanguard Group held 14,392,082 shares of Quest Diagnostics worth $2.5B as of Q4 2025.
- Vanguard Group bought 140,450 Quest Diagnostics shares in Q4 2025, an estimated $25.6M.
- Quest Diagnostics made up 0.04% of Vanguard Group's portfolio in Q4 2025, its #429 holding.
- Vanguard Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Quest Diagnostics position peaked at $2.72B in Q3 2025.
- 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.